Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/1999
10/13/1999EP0948529A1 Human galanin receptor galr2 and nucleotides encoding same
10/13/1999EP0948528A2 $i(STREPTOCOCCUS UBERIS) LACTOFERRIN-BINDING PROTEIN
10/13/1999EP0948518A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
10/13/1999EP0948517A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF
10/13/1999EP0948516A1 Method for determining expression of aberrant forms of apc protein
10/13/1999EP0948508A1 Novel coding sequences from herpes simplex virus type-2
10/13/1999EP0948398A1 Solid supports for analytical measuring processes, a process for their preparation, and their use
10/13/1999EP0948356A1 Agent for identifying and treating metastasizing tumours
10/13/1999EP0948351A1 Synthetic hpv16 virus-like particles
10/13/1999EP0948344A1 Synthetic antibiotics
10/13/1999EP0948323A1 Protease-activated receptor 3 and uses thereof
10/13/1999EP0948254A1 Cell control used to confirm enzymatic activity
10/13/1999EP0936912A4 Inhibitors of cysteine protease
10/13/1999EP0923730A4 Prenatal screening for down's syndrome using hyperglycosylated gonadotropin
10/13/1999EP0858594A4 Optical carbon dioxide sensor, and associated methods of manufacture and use
10/13/1999EP0804746A4 Fluorescence detection apparatus
10/13/1999EP0793502A4 Novel hedgehog-derived polypeptides
10/13/1999EP0757588B1 Method of controlling density of ligand coupled onto supports and products produced therefrom
10/13/1999EP0733121A4 Method of synthesizing a fluorescently labeled protein
10/13/1999EP0672192B1 Method for inhibition of viral morphogenesis
10/13/1999EP0618968B1 Tools for the diagnosis and treatment of alzheimer's disease
10/13/1999EP0603307B1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same
10/13/1999EP0567575B1 Cytokine-induced protein, tsg-6, dna coding therefor and uses thereof
10/13/1999EP0564592B1 Liver enriched transcription factor
10/13/1999CN2343587Y Producing oil parameter group-controlled monitor
10/13/1999CN1231728A Process for identifying active substance
10/13/1999CN1231696A Homocysteine desulphurase from the protozoan trichomonas vaginalis
10/13/1999CN1231695A HBV polyase, RNase H originated from HBV polyase, its preparation process and application in sieving antivirotic agent
10/13/1999CN1231673A Polynucleotide and its use for modulating a defence response in plants
10/13/1999CN1231424A Reagent for quick diagnosing human and animal trichinosis and preparation process thereof
10/12/1999US5966683 Apparatus and method for analyzing chemical system data
10/12/1999US5966676 Calibration-inability warning method in analyzing apparatus
10/12/1999US5965888 Prediction of the properties of board by using a spectroscopic method combined with multivariate calibration
10/12/1999US5965805 Apparatus and method for determining the air entrainment characteristics of liquids
10/12/1999US5965802 Niobium oxide crystals
10/12/1999US5965801 Apparatus for rapid measurement of hydrogen concentration and its use in the measurement of nitrogenase activity
10/12/1999US5965750 High- purity tocopherol phosphates, process for the preparation thereof, methods for analysis thereof, and cosmetics
10/12/1999US5965720 With sequence complementary to messenger rna from a gene selected from the group consisting of c-myc, c-myb, c-fos, c-kit, ras and bcr/abl; antisense/anticarcinogenic agents
10/12/1999US5965713 Dye labeled protein conjugate its preparing method and sensor using the same
10/12/1999US5965710 An immunoglobulin which binds human membrane-bound carcinoembryonic antigen; anticarcinogenic agent
10/12/1999US5965704 Class two cytokine receptor-11
10/12/1999US5965703 Bcl-x/bcl-2 associated death polypeptide; used for regulating apoptosis in treating acquired immune deficiency syndrome and neurodegenerative diseases; antiischemic agents
10/12/1999US5965523 Promoting angiogenesis by administering scatter factor
10/12/1999US5965458 Immunoassay test strips having a backing sheet and a test membrane with a sample absorbing end opposite to an immunochemical reagant zone and a transparent cover producing an air gap in the reagent zone between supporting pads
10/12/1999US5965457 Methods of screening for a candidate compound able to bind to CD34+ cells
10/12/1999US5965456 Analyte detection
10/12/1999US5965455 Ryegrass pollen allergen
10/12/1999US5965454 Automated histo-cytochemistry apparatus and encapsulation system for processing biological materials
10/12/1999US5965453 A test apparatus with a transparent tube having at one end a sample unit, the other end a detachable or nondetachable unit which are connected, and includes a cover with a probe and a swab at one end; rapid, efficient and disposable apparatus
10/12/1999US5965452 Multiplexed active biologic array
10/12/1999US5965451 Use of a gas sensor for the selective detection of hydrocarbons in low-oxygen gases
10/12/1999US5965449 Method of assessing risk for cardiovascular disease and other disorders and phytosterol-based compositions useful in preventing and treating cardiovascular disease and other disorders
10/12/1999US5965437 Method of screening a compound for hematopoietic activity
10/12/1999US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens
10/12/1999US5965417 Arabidepsi thaliana proteins having Δ-5,7-sterol-Δ-7-reductase activity
10/12/1999US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999US5965406 A genetically engineered molecule having a cell-binding domain, a translocation domain covalently bond to a toxin and an enzymatically active polypeptide; gene therapy, treatment of acquired immune deficieny syndrome
10/12/1999US5965396 Human lymph node derived GTPase
10/12/1999US5965385 Modification of pertussis toxin
10/12/1999US5965382 Nucleic acid encoding secreted Mac-2 binding glycoprotein
10/12/1999US5965379 Method for measuring endogenous cytokines
10/12/1999US5965378 Antibodies and/or antibody fragments which bind fd section of heavy chain of at least one class of immunoglobulins g, a, d, e and partially suppress binding of immunoglobulins to antigen; for pretreatment of immunoassay samples
10/12/1999US5965377 Screening for susceptibility to breast and ovarian cancer; using an antibody based method, targeting specific carboxy-terminus mutations in protein expressed in epithelial cells, measuring antibody reactivity with protein
10/12/1999US5965376 Evaluating cytotoxic compounds by exposing cells to test compound, measuring amount of fluid-soluble interior nuclear matrix protein released, comparing amount to standard; anticarcinogenic/antitumor/antiischemic/antihypoxic agents
10/12/1999US5965375 Diagnostic tests and kits for Clostridium difficile
10/12/1999US5965374 Glucan-specific assay
10/12/1999US5965373 Identifying enzyme inhibitors by combining a dimeric protein with a substrate, and a compound believed to be an inhibitor and determining activity of the protein on the substrate; diagnosis of epithelial cancer
10/12/1999US5965368 Determining protein-protein interactions by counterselection of two test proteins expressed in two separate nucleic acid libraries and measuring level of expression of reporter gene operably linked to a dna-binding-protein recognition sites
10/12/1999US5965366 Determining the protein binding pattern of an oligonucleotide probe in a patient lymphocyte sample and a healthy idividual, comparing patterns of binding, assessing the immune index of the patient
10/12/1999US5965360 Diagnosis of metastatic cancer by the mts-1 gene
10/12/1999US5965359 Mixing cells from biological sample with detectable labeled complementary dna probe, detecting the presence of the probe that hybridizes with messenger rna for human platelet-derived growth factor receptor gene
10/12/1999US5965358 Providing an aliquot, producing charged fragments from the aliquot, detecting fragments by a detector which produces a signal corresponding to the mass-to-charge ratio of the detected fragments, evaluating purity using a standard signal
10/12/1999US5965357 Peptides structures and their use in diagnosis of herpes simplex virus type 2
10/12/1999US5965356 Distinguishing between herpes simplex virus 1 or virus 2 by mixing serums samples with antigen having a protein kinase domain of herpes simplex-2 and a fused marker, detecting antigen-antibody binding
10/12/1999US5965355 Screening for grapevine leafroll-associcated virus 8 infection by binding the viral rna polypeptide with monoclonal antibody, detecting the bound antibody
10/12/1999US5965354 Obtaining biological sample with suspected antibody, reacting sample with type-specific antigens bound to solid support, allowing binding of antibodies to antigen, detecting with labeled immunoglobulin
10/12/1999US5965353 An epitope; for a diagnostic kit
10/12/1999US5965352 Methods for identifying pathways of drug action
10/12/1999US5965136 Bone resorption assay
10/12/1999US5965133 Self-assembling multimeric nucleic acid constructs
10/12/1999US5965131 Galactosylated clearing agent binds to the primary binding site of the primary targeting species, and only non-bound primary targeting species is cleared, not bound species second site is not blocked by the clearing agent
10/12/1999US5965070 Fractionated agaroid compositions, their preparation, and use
10/12/1999US5964999 Methods for profiling oligosaccharides released from glycoproteins
10/12/1999US5964994 Composition and method for manufacturing ion selective electrode sensors
10/12/1999US5964984 Method and apparatus for working up a sample of liquid
10/12/1999US5964712 Apparatus and breathing bag for spectrometrically measuring isotopic gas
10/12/1999CA2155028C Non-radioactive method for detecting a labelled segment and a solution or composition therefor
10/12/1999CA2099433C Enhancement of signal in immunoassays using microparticles which contain different detectable substances
10/12/1999CA1340781C Tumor specific monoclonal antibodies
10/07/1999WO1999050673A1 Solid-phase method for antigen and antibody determinations in bloodgroup serology, and test kit
10/07/1999WO1999050672A1 Assay for growth differentiation factor 9
10/07/1999WO1999050671A2 Toso as a target for drug screening
10/07/1999WO1999050670A1 Pf-4 receptor assay
10/07/1999WO1999050669A1 Methods for screening compound libraries
10/07/1999WO1999050668A1 Apparatus for screening compound libraries
10/07/1999WO1999050667A1 Electrospray device for mass spectrometer
10/07/1999WO1999050666A1 Determination of the probability of bone metastases in patients with primary carcinomas
10/07/1999WO1999050665A1 Microassay device and methods
10/07/1999WO1999050664A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
10/07/1999WO1999050663A1 METHOD FOR EXAMINING IgA NEPHROPATHY
1 ... 3182 3183 3184 3185 3186 3187 3188 3189 3190 3191 3192 3193 3194 3195 3196 3197 3198 3199 3200 3201 3202 ... 3937